SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced financial results for the first quarter of 2007. For the quarter ended March 31, 2007, the Company reported a net loss of $6.5 million (or $.22 per share), compared to a net loss of $6.9 million (or $0.30 per share) in the first quarter of 2006.
